Back to Search
KEITH WHITEMAN, PHARMD
PHARMD
Pharmacist
NPI: 1801301908Individual
Specialties, Licenses & Credentials
Research & Publications (11)
Semisynthetic maytansine analogues for the targeted treatment of cancer.
PMID 16821799·J Med Chem·2006
7-preclinical
Implementing a standardized safety procedure for continuous renal replacement therapy solutions.
PMID 16595818·Am J Health Syst Pharm·2006
5-case
In vitro and in vivo activity of the maytansinoid immunoconjugate huN901-N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl)-maytansine against CD56+ multiple myeloma cells.
PMID 15231675·Cancer Res·2004
7-preclinical
Cytotoxic activity of the maytansinoid immunoconjugate B-B4-DM1 against CD138+ multiple myeloma cells.
PMID 15292058·Blood·2004
7-preclinical
Liposome clearance in mice: the effect of a separate and combined presence of surface charge and polymer coating.
PMID 12062505·Int J Pharm·2002
7-preclinical
p-Nitrophenylcarbonyl-PEG-PE-liposomes: fast and simple attachment of specific ligands, including monoclonal antibodies, to distal ends of PEG chains via p-nitrophenylcarbonyl groups.
PMID 11286983·Biochim Biophys Acta·2001
7-preclinical
Amphiphilic poly-N-vinylpyrrolidones: synthesis, properties and liposome surface modification.
PMID 11575478·Biomaterials·2001
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Request Appointment
This provider isn't set up for online booking yet. Once you submit, we'll reach out to their office to arrange secure delivery of your request.
Contact & Hours
- Address
- 1870 E HISTORIC HIGHWAY 66
GALLUP, NM 87301 - Phone
- (505) 722-9499
Quick Facts
- NPI
- 1801301908
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 11
Are you this provider?
Claim Your Profile